Cue Biopharma, Inc.

CUE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$22,459$48,514$51,614$64,371
Short-Term Investments$929$0$24,675$0
Receivables$945$1,698$57$3,143
Inventory$0$0$0$0
Other Curr. Assets$805$1,242$841$955
Total Curr. Assets$25,138$51,454$77,187$68,468
Property Plant & Equip (Net)$4,841$7,118$10,702$11,922
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$151$0$150
Tax Assets$0$0$0$0
Other NC Assets$2,212$2,807$3,394$2,861
Total NC Assets$7,053$10,076$14,096$14,933
Other Assets$0$0$0$0
Total Assets$32,191$61,530$91,283$83,401
Liabilities
Payables$2,823$3,501$2,731$2,591
Short-Term Debt$7,873$7,331$5,263$6,900
Tax Payable$0$0$0$0
Deferred Revenue$0$2,112$0$645
Other Curr. Liab.$2,993$4,137$3,554$2,652
Total Curr. Liab.$13,689$17,081$11,548$12,788
LT Debt$1,003$7,364$14,053$5,121
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,003$7,364$14,053$5,121
Other Liabilities$0$0$0$0
Cap. Leases$4,543$6,530$9,318$10,053
Total Liabilities$14,692$24,445$25,601$17,909
Equity
Pref Stock$0$0$0$0
Common Stock$62$47$43$32
Retained Earnings-$341,864-$301,190-$250,457-$197,446
AOCI$0$0-$96$0
Other Equity$359,301$338,228$316,192$262,906
Total Equity$17,499$37,085$65,682$65,492
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$32,191$61,530$91,283$83,401
Net Debt-$13,583-$33,819-$32,298-$52,350
Cue Biopharma, Inc. (CUE) Financial Statements & Key Stats | AlphaPilot